{
  "ticker": "JNJ",
  "target_date": "2025-11-18",
  "actual_date": "2025-11-18",
  "collected_at": "2025-12-08T12:32:56.515630",
  "price": {
    "open": 197.75,
    "high": 199.04,
    "low": 197.28,
    "close": 198.73817443847656,
    "volume": 12468600,
    "change_1d_pct": 0.21,
    "change_7d_pct": 7.2,
    "change_30d_pct": 5.88
  },
  "technicals": {
    "rsi_14": 81.16,
    "sma_20": 189.68,
    "sma_50": 185.55,
    "macd": 2.739,
    "macd_signal": 1.705,
    "macd_histogram": 1.035,
    "bb_upper": 198.5,
    "bb_lower": 180.85,
    "price_vs_sma20_pct": 4.78,
    "price_vs_sma50_pct": 7.11,
    "volume_ratio": 1.54
  },
  "fundamentals": {
    "market_cap": 488279769088,
    "pe_ratio": 19.562258,
    "forward_pe": 19.119339,
    "price_to_book": 6.1512427,
    "price_to_sales": 5.298807,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.48,
    "pct_from_52w_low": 44.06
  },
  "macro": {
    "spy": {
      "price": 660.08,
      "change_1d_pct": -0.84,
      "change_7d_pct": -3.13
    },
    "vix": {
      "level": 24.69,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.12
    },
    "dollar_index": {
      "level": 99.55
    },
    "gold": {
      "price": 4061.3
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Why Johnson & Johnson (JNJ) Is Up 5.9% After Multiple FDA Approvals and Positive Drug Trial Results",
      "source": "Yahoo",
      "datetime": 1763503790,
      "summary": "In November 2025, Johnson & Johnson announced several major product developments, including new FDA approvals for DARZALEX Faspro in high-risk smoldering multiple myeloma, CAPLYTA as an adjunctive treatment for major depressive disorder, and positive late-stage clinical results for TREMFYA in psoria",
      "url": "https://finnhub.io/api/news?id=5e378aec114b6ff929553cf5ac12bd027bfe4c331eea860345ab36f19b2ec9cc"
    },
    {
      "headline": "Tracking Jeremy Grantham's GMO Capital Portfolio - Q3 2025 Update",
      "source": "SeekingAlpha",
      "datetime": 1763494170,
      "summary": "GMO's Q3 2025 13F portfolio rose to $35.46B, with Microsoft, Alphabet, Meta, Apple, and Lam Research as top holdings. Learn more about the portfolio here.",
      "url": "https://finnhub.io/api/news?id=b05438074d046bb3e4c76ce9412b9f313458cdfe24056dbddb7b2b3d89563f27"
    },
    {
      "headline": "J&J Joins Pharma M&A Bandwagon, to Buy Cancer Biotech for $3.05B",
      "source": "Yahoo",
      "datetime": 1763481780,
      "summary": "J&J's $3.05B move for Halda adds targeted oral cancer therapies and expands its prostate cancer pipeline amid rising pharma M&A.",
      "url": "https://finnhub.io/api/news?id=67e977e368a968c7bc7045c9ca20be6853bff35dabe6917f0082cd1dca113578"
    },
    {
      "headline": "3 Smart Defensive Stocks for an Uneasy Market",
      "source": "Yahoo",
      "datetime": 1763478420,
      "summary": "Recession risks persist despite record market highs. Here are three defensive stocks\u2014including PG, JNJ, and the DIA ETF\u2014that can help protect your portfolio",
      "url": "https://finnhub.io/api/news?id=492800796b85fcd150b1db47bef4fce161269b674278d873482d0bacac1ee72e"
    },
    {
      "headline": "Here's How Neuroscience Drugs Aided AbbVie's Top-line Growth in Q3",
      "source": "Yahoo",
      "datetime": 1763476620,
      "summary": "ABBV's neuroscience drugs drive strong Q3 momentum, with rising Botox Therapeutic sales, migraine therapies and new PD treatments fueling growth.",
      "url": "https://finnhub.io/api/news?id=22a9b2877ce98a0a211de4955eb9774799578c2b464b854ce5f88ed82b6dbb8e"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-11-14",
      "description": "xslF345X05/ownership.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525282669/xslF345X05/ownership.xml"
    },
    {
      "form": "13F-HR",
      "date": "2025-11-13",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000587/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-11-10",
      "description": "xslF345X05/ownership.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525274067/xslF345X05/ownership.xml"
    },
    {
      "form": "10-Q",
      "date": "2025-10-22",
      "description": "jnj-20250928.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/jnj-20250928.htm"
    },
    {
      "form": "4",
      "date": "2025-10-20",
      "description": "xslF345X05/wk-form4_1761002033.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000204/xslF345X05/wk-form4_1761002033.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}